{"hands_on_practices": [{"introduction": "To effectively combat antibiotic resistance, we must first understand its origins at the molecular level. For vancomycin, a cornerstone glycopeptide, resistance often arises from a subtle yet profound alteration in the drug's target. This practice explores the thermodynamic consequences of the D-alanyl-D-alanine to D-alanyl-D-lactate substitution in bacterial peptidoglycan precursors, which is the hallmark of high-level vancomycin resistance. By applying the fundamental relationship between binding free energy and equilibrium constants, you will quantify the dramatic loss of binding affinity caused by this single atomic change, providing a concrete measure of the challenge that resistance presents [@problem_id:4645580].", "problem": "Vancomycin, a glycopeptide antibiotic, binds the peptidoglycan terminus D-alanyl-D-alanine (D-Ala-D-Ala) in susceptible bacteria through specific hydrogen bonding and steric complementarity. In vancomycin-resistant enterococci, substitution of the terminal dipeptide to D-alanyl-D-lactate (D-Ala-D-Lac) disrupts critical hydrogen bonding and increases the binding free energy. Let the change in binding free energy upon this substitution be defined as $\\Delta\\Delta G \\equiv \\Delta G_{\\text{bind}}^{\\text{D-Ala-D-Lac}} - \\Delta G_{\\text{bind}}^{\\text{D-Ala-D-Ala}}$, and suppose $\\Delta\\Delta G = +2.5$ kilocalories per mole, indicating weaker binding to the D-Ala-D-Lac terminus. Using the fundamental thermodynamic relation between binding free energy and the equilibrium constant for association, $\\Delta G_{\\text{bind}} = - R T \\ln K_{\\text{a}}$, where $R$ is the universal gas constant and $T$ is the absolute temperature, derive an expression for the fold reduction in binding affinity defined as the ratio $K_{\\text{a}}^{\\text{D-Ala-D-Ala}} / K_{\\text{a}}^{\\text{D-Ala-D-Lac}}$. Then compute this fold reduction at $T = 310$ kelvin using $R = 1.987$ calories per mole per kelvin. Treat $\\Delta\\Delta G$ as $+2.5$ kilocalories per mole and ensure unit consistency in your calculation. Express your final result as a pure number (dimensionless). Round your answer to two significant figures.", "solution": "The problem is first validated to ensure it is scientifically grounded, well-posed, and objective.\n\n### Step 1: Extract Givens\n- Definition of change in binding free energy: $\\Delta\\Delta G \\equiv \\Delta G_{\\text{bind}}^{\\text{D-Ala-D-Lac}} - \\Delta G_{\\text{bind}}^{\\text{D-Ala-D-Ala}}$\n- Value of the change in binding free energy: $\\Delta\\Delta G = +2.5$ kilocalories per mole\n- Thermodynamic relation: $\\Delta G_{\\text{bind}} = - R T \\ln K_{\\text{a}}$\n- Universal gas constant: $R = 1.987$ calories per mole per kelvin\n- Absolute temperature: $T = 310$ kelvin\n- Target expression: Fold reduction in binding affinity, defined as the ratio $K_{\\text{a}}^{\\text{D-Ala-D-Ala}} / K_{\\text{a}}^{\\text{D-Ala-D-Lac}}$\n- Calculation requirement: Compute the numerical value of the fold reduction.\n- Rounding requirement: Round the final answer to two significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded. The scenario describes the well-established biochemical mechanism of vancomycin resistance in enterococci, which involves the substitution of a D-alanine with a D-lactate at the C-terminus of the peptidoglycan precursor. This substitution eliminates a key hydrogen bond donor (the amide N-H) and introduces electrostatic repulsion, leading to a significant decrease in binding affinity. The thermodynamic equation $\\Delta G = -RT \\ln K$ is a fundamental principle of chemical thermodynamics. The provided values for the change in free energy, temperature, and the gas constant are realistic for such a biophysical system. The problem is well-posed, as all necessary information is provided to derive the expression and compute the value. The language is objective and the requirements are unambiguous. The unit mismatch between $\\Delta\\Delta G$ (in kcal/mol) and $R$ (in cal/mol/K) is not a contradiction but a standard conversion challenge in such problems, which the prompt explicitly mentions to address.\n\n### Step 3: Verdict and Action\nThe problem is valid. A complete solution will be provided.\n\n### Solution Derivation and Calculation\nThe problem requires the derivation of an expression for the fold reduction in binding affinity and its subsequent calculation. The binding affinity is quantified by the association constant, $K_{\\text{a}}$.\n\nThe fundamental relationship between the standard Gibbs free energy of binding, $\\Delta G_{\\text{bind}}$, and the association constant, $K_{\\text{a}}$, is given by:\n$$ \\Delta G_{\\text{bind}} = - R T \\ln K_{\\text{a}} $$\nwhere $R$ is the universal gas constant and $T$ is the absolute temperature.\n\nThis relationship can be written for both the susceptible (D-Ala-D-Ala) and resistant (D-Ala-D-Lac) termini:\n1. For vancomycin binding to D-Ala-D-Ala:\n$$ \\Delta G_{\\text{bind}}^{\\text{D-Ala-D-Ala}} = - R T \\ln K_{\\text{a}}^{\\text{D-Ala-D-Ala}} $$\n2. For vancomycin binding to D-Ala-D-Lac:\n$$ \\Delta G_{\\text{bind}}^{\\text{D-Ala-D-Lac}} = - R T \\ln K_{\\text{a}}^{\\text{D-Ala-D-Lac}} $$\n\nThe problem defines the change in binding free energy upon substitution as:\n$$ \\Delta\\Delta G = \\Delta G_{\\text{bind}}^{\\text{D-Ala-D-Lac}} - \\Delta G_{\\text{bind}}^{\\text{D-Ala-D-Ala}} $$\n\nSubstituting the expressions for the Gibbs free energies into this definition:\n$$ \\Delta\\Delta G = \\left( - R T \\ln K_{\\text{a}}^{\\text{D-Ala-D-Lac}} \\right) - \\left( - R T \\ln K_{\\text{a}}^{\\text{D-Ala-D-Ala}} \\right) $$\n$$ \\Delta\\Delta G = R T \\ln K_{\\text{a}}^{\\text{D-Ala-D-Ala}} - R T \\ln K_{\\text{a}}^{\\text{D-Ala-D-Lac}} $$\n\nFactoring out the term $R T$:\n$$ \\Delta\\Delta G = R T \\left( \\ln K_{\\text{a}}^{\\text{D-Ala-D-Ala}} - \\ln K_{\\text{a}}^{\\text{D-Ala-D-Lac}} \\right) $$\n\nUsing the logarithmic identity $\\ln(a) - \\ln(b) = \\ln(a/b)$, we get:\n$$ \\Delta\\Delta G = R T \\ln \\left( \\frac{K_{\\text{a}}^{\\text{D-Ala-D-Ala}}}{K_{\\text{a}}^{\\text{D-Ala-D-Lac}}} \\right) $$\n\nThe term inside the logarithm, $\\frac{K_{\\text{a}}^{\\text{D-Ala-D-Ala}}}{K_{\\text{a}}^{\\text{D-Ala-D-Lac}}}$, is precisely the fold reduction in binding affinity. To find an expression for this ratio, we rearrange the equation:\n$$ \\frac{\\Delta\\Delta G}{R T} = \\ln \\left( \\frac{K_{\\text{a}}^{\\text{D-Ala-D-Ala}}}{K_{\\text{a}}^{\\text{D-Ala-D-Lac}}} \\right) $$\n\nExponentiating both sides with base $e$ gives the desired symbolic expression for the fold reduction:\n$$ \\frac{K_{\\text{a}}^{\\text{D-Ala-D-Ala}}}{K_{\\text{a}}^{\\text{D-Ala-D-Lac}}} = \\exp\\left( \\frac{\\Delta\\Delta G}{R T} \\right) $$\n\nNow, we compute the numerical value for this ratio using the provided data.\nGiven values:\n- $\\Delta\\Delta G = +2.5$ kcal/mol\n- $R = 1.987$ cal/(molÂ·K)\n- $T = 310$ K\n\nFirst, we must ensure unit consistency. The energy term $\\Delta\\Delta G$ is in kilocalories (kcal), while the gas constant $R$ is in calories (cal). We convert $\\Delta\\Delta G$ to calories per mole:\n$$ \\Delta\\Delta G = 2.5 \\text{ kcal/mol} \\times \\frac{1000 \\text{ cal}}{1 \\text{ kcal}} = 2500 \\text{ cal/mol} $$\n\nNow, we calculate the dimensionless argument of the exponential function, $\\frac{\\Delta\\Delta G}{R T}$:\n$$ \\frac{\\Delta\\Delta G}{R T} = \\frac{2500 \\text{ cal/mol}}{(1.987 \\text{ cal/(mol}\\cdot\\text{K)}) \\times (310 \\text{ K})} $$\n$$ \\frac{\\Delta\\Delta G}{R T} = \\frac{2500}{615.97} \\approx 4.058639 $$\n\nFinally, we calculate the fold reduction:\n$$ \\text{Fold Reduction} = \\exp(4.058639) \\approx 57.893 $$\n\nThe problem requires the result to be rounded to two significant figures. The first two digits are $5$ and $7$. The third digit is $8$, which is greater than or equal to $5$, so we round up the second digit.\n$$ 57.893 \\approx 58 $$\nExpressing this in standard scientific notation as required by the formatting rules gives $5.8 \\times 10^1$. This value represents that the binding affinity of vancomycin for the native D-Ala-D-Ala terminus is approximately $58$ times stronger than for the mutant D-Ala-D-Lac terminus.", "answer": "$$\\boxed{5.8 \\times 10^{1}}$$", "id": "4645580"}, {"introduction": "Translating molecular understanding into effective patient care requires a mastery of pharmacokinetics (PK) and pharmacodynamics (PD). For concentration-dependent antibiotics like vancomycin, the goal is to maintain a drug exposure level sufficient to overcome the pathogen's resistance, as measured by its Minimum Inhibitory Concentration (MIC). This exercise challenges you to build a dosing strategy from the ground up, starting by deriving the fundamental relationship between daily dose ($D_{24}$), drug clearance ($CL$), and total drug exposure ($AUC_{24}$) from the principle of mass balance. You will then use this derived model to calculate a precise daily dose needed to achieve a standard therapeutic target, demonstrating how first principles are used to design rational, evidence-based antibiotic regimens [@problem_id:4645670].", "problem": "A patient with methicillin-resistant Staphylococcus aureus is treated with an intravenous glycopeptide or lipopeptide antibiotic. Assume the drug follows a one-compartment, linear, time-invariant pharmacokinetic model with instantaneous distribution into the central compartment, intravenous bioavailability equal to $1$, and steady-state conditions under periodic dosing. Let $A(t)$ be the amount of drug in the body, $C(t)$ the plasma concentration, $CL$ the systemic clearance, $R_{\\text{in}}(t)$ the input rate, and $R_{\\text{out}}(t)$ the elimination rate. The Minimum Inhibitory Concentration (MIC) is defined as the lowest antimicrobial concentration that inhibits visible growth of the pathogen, and the 24-hour area under the concentration-time curve is $AUC_{24} = \\int_{0}^{24} C(t)\\,\\mathrm{d}t$.\n\nStarting strictly from mass balance and the definition of clearance, derive an analytic expression that links $AUC_{24}$, the total daily dose $D_{24}$, and $CL$ at steady state for intravenous administration, without invoking any pre-derived pharmacokinetic shortcuts.\n\nThen, using your derived expression, compute the total daily dose required to achieve the pharmacokinetic/pharmacodynamic target $AUC_{24}/MIC = 500$ for a pathogen with $MIC = 1$ mg/L, given $CL = 4$ L/h. Express the final dose in mg/day. Provide the dose as an exact value (no rounding is required).", "solution": "The problem is evaluated to be valid as it is scientifically grounded in established pharmacokinetic principles, is well-posed with sufficient and consistent information, and is expressed in objective, formal language. It is a standard problem in pharmacokinetics that can be solved from first principles.\n\nThe derivation and calculation will be performed in two parts as requested.\n\nPart 1: Derivation of the relationship between $AUC_{24}$, $D_{24}$, and $CL$.\n\nThe analysis begins with the principle of mass balance. The rate of change of the amount of drug in the body, $A(t)$, is equal to the rate of drug input, $R_{\\text{in}}(t)$, minus the rate of drug elimination, $R_{\\text{out}}(t)$. This is expressed by the differential equation:\n$$\n\\frac{dA(t)}{dt} = R_{\\text{in}}(t) - R_{\\text{out}}(t)\n$$\nFor a linear pharmacokinetic model, the elimination rate is directly proportional to the plasma concentration, $C(t)$. The constant of proportionality is the systemic clearance, $CL$.\n$$\nR_{\\text{out}}(t) = CL \\cdot C(t)\n$$\nSubstituting this into the mass balance equation gives:\n$$\n\\frac{dA(t)}{dt} = R_{\\text{in}}(t) - CL \\cdot C(t)\n$$\nTo analyze the system over a 24-hour period, we integrate this equation from $t=0$ to $t=24$ hours.\n$$\n\\int_{0}^{24} \\frac{dA(t)}{dt} \\,dt = \\int_{0}^{24} R_{\\text{in}}(t) \\,dt - \\int_{0}^{24} CL \\cdot C(t) \\,dt\n$$\nWe evaluate each term separately.\n\nThe left-hand side is the definite integral of the derivative of $A(t)$:\n$$\n\\int_{0}^{24} \\frac{dA(t)}{dt} \\,dt = A(24) - A(0)\n$$\nThe problem states that the system is at steady state under periodic dosing. At steady state, the amount of drug in the body at the end of a full cycle is the same as the amount at the beginning. Considering a 24-hour period as one such cycle, we have $A(24) = A(0)$. Therefore, the net change is zero:\n$$\nA(24) - A(0) = 0\n$$\nThe first term on the right-hand side is the integral of the input rate over 24 hours. This represents the total amount of drug that enters the systemic circulation during that period.\n$$\n\\int_{0}^{24} R_{\\text{in}}(t) \\,dt\n$$\nFor intravenous administration, the bioavailability is given as $1$, meaning the entire administered dose reaches the systemic circulation. This integral is therefore equal to the total daily dose, denoted as $D_{24}$.\n$$\n\\int_{0}^{24} R_{\\text{in}}(t) \\,dt = D_{24}\n$$\nThe second term on the right-hand side is the integral of the elimination rate. Since the model is time-invariant, the clearance $CL$ is a constant and can be factored out of the integral:\n$$\n\\int_{0}^{24} CL \\cdot C(t) \\,dt = CL \\cdot \\int_{0}^{24} C(t) \\,dt\n$$\nThe problem defines the 24-hour area under the concentration-time curve as $AUC_{24} = \\int_{0}^{24} C(t) \\,dt$. Thus, the second term becomes:\n$$\nCL \\cdot AUC_{24}\n$$\nSubstituting these results back into the integrated mass balance equation:\n$$\n0 = D_{24} - CL \\cdot AUC_{24}\n$$\nRearranging this equation provides the direct relationship between the total daily dose, clearance, and the 24-hour area under the curve at steady state:\n$$\nD_{24} = CL \\cdot AUC_{24}\n$$\nThis completes the derivation as required, starting strictly from mass balance and the definition of clearance.\n\nPart 2: Calculation of the total daily dose.\n\nThe problem requires the calculation of the total daily dose, $D_{24}$, needed to achieve a specific pharmacokinetic/pharmacodynamic (PK/PD) target. The given values are:\nPK/PD target: $\\frac{AUC_{24}}{MIC} = 500$\nMinimum Inhibitory Concentration (MIC): $MIC = 1 \\, \\text{mg/L}$\nSystemic Clearance (CL): $CL = 4 \\, \\text{L/h}$\n\nFirst, we determine the required target value for $AUC_{24}$ using the given PK/PD index and MIC value.\n$$\nAUC_{24} = 500 \\cdot MIC\n$$\n$$\nAUC_{24} = 500 \\cdot (1 \\, \\text{mg/L}) = 500 \\, \\frac{\\text{mg} \\cdot \\text{h}}{\\text{L}}\n$$\nNext, we use the expression derived in Part 1 to calculate the total daily dose, $D_{24}$.\n$$\nD_{24} = CL \\cdot AUC_{24}\n$$\nSubstituting the given value for $CL$ and the calculated value for $AUC_{24}$:\n$$\nD_{24} = \\left(4 \\, \\frac{\\text{L}}{\\text{h}}\\right) \\cdot \\left(500 \\, \\frac{\\text{mg} \\cdot \\text{h}}{\\text{L}}\\right)\n$$\nThe units are consistent: $\\frac{\\text{L}}{\\text{h}} \\cdot \\frac{\\text{mg} \\cdot \\text{h}}{\\text{L}} = \\text{mg}$. The resulting quantity is the total mass of drug to be administered over 24 hours, which is the daily dose.\n$$\nD_{24} = 4 \\cdot 500 \\, \\text{mg} = 2000 \\, \\text{mg}\n$$\nThe required total daily dose is $2000$ mg/day. The problem asks for an exact value, which this is.", "answer": "$$\\boxed{2000}$$", "id": "4645670"}, {"introduction": "A successful therapeutic strategy involves more than just calculating the correct dose; it also demands safe administration. Vancomycin provides a classic case study with its potential to cause Red Man Syndrome, an infusion-rate-dependent adverse reaction. This final practice moves from the 'what' and 'how much' of dosing to the 'how fast' of delivery. Here, you will use basic physical principles to determine the minimum safe infusion time for a standard vancomycin dose, ensuring the mass delivery rate remains below the clinically recommended threshold. This exercise bridges the gap between pharmacokinetic theory and the practical realities of bedside patient safety [@problem_id:4645595].", "problem": "A patient with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia requires an intravenous (IV) dose of the glycopeptide antibiotic vancomycin. Rapid infusion of vancomycin can precipitate Red Man Syndrome (RMS), a non-immunoglobulin E (IgE) mediated reaction linked to mast cell degranulation that correlates with the instantaneous mass infusion rate rather than the total dose. To minimize RMS risk, the recommended maximum vancomycin mass infusion rate is $\\leq 10 \\, \\mathrm{mg/min}$. The pharmacy prepares a $1$ $\\mathrm{g}$ vancomycin dose diluted in $250$ $\\mathrm{mL}$ of normal saline, delivered using an infusion pump that maintains a constant volumetric flow rate.\n\nUsing first principles, derive the minimum infusion time $t_{\\min}$ necessary to ensure the mass infusion rate constraint is not violated under constant-rate infusion. Your derivation should begin from the definition of mass flow rate and avoid any assumptions that bypass this derivation. As a consistency check, relate the mass infusion rate to the volumetric pump setting via the solution concentration. Provide the final numerical value for $t_{\\min}$ in minutes. Round your answer to three significant figures and express the final answer in minutes.", "solution": "The problem statement is first subjected to a rigorous validation process.\n\n### Step 1: Extract Givens\nThe following data and constraints are explicitly provided in the problem statement:\n-   Total mass of vancomycin to be infused, $m_{total} = 1$ g.\n-   Total volume of the saline solution, $V_{total} = 250$ mL.\n-   The infusion pump maintains a constant volumetric flow rate.\n-   The maximum permissible mass infusion rate, $\\dot{m}_{max}$, is given by the constraint $\\dot{m} \\leq 10$ mg/min.\n-   The goal is to derive the minimum infusion time, $t_{min}$, from first principles.\n-   A consistency check is required, relating mass infusion rate to volumetric flow rate and concentration.\n-   The final numerical answer for $t_{min}$ must be in minutes and rounded to three significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is evaluated against the established criteria for validity.\n\n-   **Scientifically Grounded**: The problem is based on established principles of clinical pharmacology and pharmacokinetics. The drug (vancomycin), its common dosage ($1$ g), dilution volume ($250$ mL), the clinical condition (MRSA bacteremia), the adverse effect (Red Man Syndrome), and the rate-dependent mechanism of this effect are all factually correct and standard in medical practice. The specified maximum infusion rate of $10$ mg/min is the widely accepted clinical guideline to prevent this reaction.\n-   **Well-Posed**: The problem is well-posed. It provides sufficient information (total mass and maximum rate) to uniquely determine the requested quantity (minimum time).\n-   **Objective**: The problem is stated using precise, objective, and quantitative language, free from any subjectivity or ambiguity.\n\nBased on this evaluation, the problem does not violate any of the invalidity criteria. It is scientifically sound, self-contained, and calls for a straightforward application of physical principles to a realistic clinical scenario.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. A solution will be derived.\n\n### Solution Derivation\n\nThe mass infusion rate, denoted as $\\dot{m}$, is defined as the rate of change of mass delivered over time. Mathematically, it is the time derivative of the infused mass, $m(t)$:\n$$\n\\dot{m}(t) = \\frac{dm}{dt}\n$$\nThe problem states that the infusion occurs at a constant rate. For a constant-rate process, the instantaneous rate is equal to the average rate over the entire duration of the infusion. Therefore, a constant mass infusion rate, $\\dot{m}$, can be expressed as the total mass infused, $m_{total}$, divided by the total infusion time, $t_{infusion}$:\n$$\n\\dot{m} = \\frac{m_{total}}{t_{infusion}}\n$$\nThe clinical constraint is that this mass infusion rate must not exceed a maximum value, $\\dot{m}_{max}$, to prevent Red Man Syndrome.\n$$\n\\dot{m} \\leq \\dot{m}_{max}\n$$\nwhere $\\dot{m}_{max} = 10 \\text{ mg/min}$.\n\nSubstituting the expression for the constant rate into the inequality gives:\n$$\n\\frac{m_{total}}{t_{infusion}} \\leq \\dot{m}_{max}\n$$\nWe wish to find the minimum possible infusion time, $t_{min}$. To minimize the time, the infusion rate must be maximized to its upper limit. Therefore, we set the infusion rate equal to the maximum allowed rate:\n$$\n\\frac{m_{total}}{t_{min}} = \\dot{m}_{max}\n$$\nSolving for $t_{min}$:\n$$\nt_{min} = \\frac{m_{total}}{\\dot{m}_{max}}\n$$\nThis equation represents the derived minimum infusion time from first principles.\n\nBefore calculating the numerical value, we perform the requested consistency check by relating the mass infusion rate to the volumetric pump setting.\n\nThe concentration, $C$, of the vancomycin solution is defined as the total mass of the drug divided by the total volume of the solution:\n$$\nC = \\frac{m_{total}}{V_{total}}\n$$\nThe infusion pump operates at a constant volumetric flow rate, $\\dot{V}$. The mass infusion rate, $\\dot{m}$, is the product of the solution's concentration and its volumetric flow rate:\n$$\n\\dot{m} = C \\cdot \\dot{V}\n$$\nThis establishes the required relationship. The constraint on the mass infusion rate can be rewritten in terms of the volumetric flow rate:\n$$\nC \\cdot \\dot{V} \\leq \\dot{m}_{max}\n$$\nThis implies that the maximum permissible volumetric flow rate, $\\dot{V}_{max}$, is:\n$$\n\\dot{V}_{max} = \\frac{\\dot{m}_{max}}{C}\n$$\nThe total infusion time is the total volume divided by the constant volumetric flow rate, $t_{infusion} = \\frac{V_{total}}{\\dot{V}}$. The minimum time, $t_{min}$, is achieved by using the maximum volumetric flow rate, $\\dot{V}_{max}$:\n$$\nt_{min} = \\frac{V_{total}}{\\dot{V}_{max}} = \\frac{V_{total}}{(\\dot{m}_{max} / C)}\n$$\nSubstituting the expression for concentration $C = \\frac{m_{total}}{V_{total}}$ into this equation:\n$$\nt_{min} = \\frac{V_{total}}{\\dot{m}_{max} / (m_{total} / V_{total})} = \\frac{V_{total} \\cdot m_{total}}{\\dot{m}_{max} \\cdot V_{total}} = \\frac{m_{total}}{\\dot{m}_{max}}\n$$\nThis result is identical to the one derived directly from the definition of mass flow rate, confirming the consistency of the physical model.\n\nNow, we proceed with the numerical calculation. The given values are:\n-   $m_{total} = 1$ g\n-   $\\dot{m}_{max} = 10$ mg/min\n\nThe units must be consistent. We convert the total mass from grams (g) to milligrams (mg):\n$$\nm_{total} = 1 \\text{ g} \\times \\frac{1000 \\text{ mg}}{1 \\text{ g}} = 1000 \\text{ mg}\n$$\nNow, substitute the numerical values into the equation for $t_{min}$:\n$$\nt_{min} = \\frac{1000 \\text{ mg}}{10 \\text{ mg/min}} = 100 \\text{ min}\n$$\nThe problem requires the answer to be rounded to three significant figures. The exact result is $100$. To express this integer with three significant figures unambiguously, it is best written in scientific notation.\n\n$t_{min} = 100$ min, which to three significant figures is $1.00 \\times 10^2$ min.", "answer": "$$\\boxed{1.00 \\times 10^{2}}$$", "id": "4645595"}]}